The clinical and biological significance of HER2 over-expression in breast ductal carcinoma in situ: A large study from a single institution

(Cancer Research UK) Upcoming publication from the British Journal of Cancer, investigating HER2 expression as a predictor of recurrence and development in patients with DCIS.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news

Related Links:

More News: Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Carcinoma in Situ | DCIS (Ductal Carcinoma in Situ) | Ductal Carcinoma | HER2 | Study | UK Health